v3.26.3
DERIVATIVE FINANCIAL INSTRUMENTS AND HEDGING ACTIVITIES (Tables)
9 Months Ended
Sep. 30, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Income Effect of Derivative Financial Instruments
The gains/(losses), by hedge designation, reported in income for the periods ended September 30 were as follows (in millions):
Third QuarterFirst Nine Months
Cash flow hedges
2025202620252026
Reclassified from AOCI to Cost of sales
Foreign currency exchange contracts (a)
$(23)$6 $72 $3 
Commodity contracts (b)
— 36 10 123 
Fair value hedges
Interest rate contracts
Net interest settlements and accruals on hedging instruments
(45)— (137)(14)
Fair value changes on hedging instruments34 (861)598 (1,226)
Fair value changes on hedged debt(33)832 (576)1,188 
Cross-currency interest rate swap contracts
Net interest settlements and accruals on hedging instruments
(23)(15)(66)(41)
Fair value changes on hedging instruments(14)(193)490 (433)
Fair value changes on hedged debt(1)189 (476)422 
Derivatives not designated as hedging instruments
Foreign currency exchange contracts (c)(55)23 (64)(13)
Cross-currency interest rate swap contracts
(49)(45)299 (119)
Interest rate contracts— 173 (63)265 
Commodity contracts— 23 22 51 
Total$(209)$168 $109 $206 
__________
(a)For the third quarter and first nine months of 2025, a $331 million gain and a $274 million loss, respectively, were reported in Other comprehensive income/(loss), net of tax. For the third quarter and first nine months of 2026, a $73 million loss and a $156 million gain, respectively, were reported in Other comprehensive income/(loss), net of tax.
(b)For the third quarter and first nine months of 2025, a $30 million gain and a $38 million gain, respectively, were reported in Other comprehensive income/(loss), net of tax. For the third quarter and first nine months of 2026, a $35 million gain and a $75 million gain, respectively, were reported in Other comprehensive income/(loss), net of tax.
(c)For the third quarter and first nine months of 2025, a $61 million loss and a $65 million gain, respectively, were reported in Cost of sales, and a $6 million gain and a $129 million loss, respectively, were reported in Other income/(loss), net. For the third quarter and first nine months of 2026, a $20 million loss and a $132 million loss, respectively, were reported in Cost of sales, and a $43 million gain and a $119 million gain, respectively, were reported in Other income/(loss), net.
Schedule of Balance Sheet Effect of Derivative Instruments
The fair value of our derivative instruments and the associated notional amounts were as follows (in millions):
December 31, 2025September 30, 2026
NotionalFair Value of
Assets
Fair Value of
Liabilities
NotionalFair Value of
Assets
Fair Value of
Liabilities
Cash flow hedges
Foreign currency exchange contracts
$17,750 $98 $114 $13,998 $231 $117 
Commodity contracts940 122 — 1,066 80 10 
Fair value hedges
Interest rate contracts18,582 374 220 22,167 6 879 
Cross-currency interest rate swap contracts
4,158 383 5 6,330 166 217 
Derivatives not designated as hedging instruments
Foreign currency exchange contracts24,934 150 180 23,600 159 214 
Cross-currency interest rate swap contracts
7,121 379 28 6,257 191 70 
Interest rate contracts87,293 364 619 86,290 826 704 
Commodity contracts803 56 1 967 29 24 
Total derivative financial instruments, gross (a) (b)
$161,581 $1,926 $1,167 $160,675 $1,688 $2,235 
Current portion
$634 $643 $641 $875 
Non-current portion
1,292 524 1,047 1,360 
Total derivative financial instruments, gross
$1,926 $1,167 $1,688 $2,235 
__________
(a)At December 31, 2025 and September 30, 2026, we held collateral of $5 million and $50 million, respectively, and we posted collateral of $102 million and $139 million, respectively.
(b)At December 31, 2025 and September 30, 2026, the fair value of assets and liabilities available for counterparty netting was $814 million and $1,033 million, respectively. All derivatives are categorized within Level 2 of the fair value hierarchy.